跳转至内容
Merck
CN
所有图片(1)

主要文件

安全信息

SCP0110

Sigma-Aldrich

组织蛋白酶抑制剂

登录查看公司和协议定价
所有图片(1)

About This Item

经验公式（希尔记法）:
C35H59N11O5
分子量:
713.91
UNSPSC代码:
12352200
NACRES:
NA.32

方案

≥95% (HPLC)

表单

lyophilized

组成

Peptide Content, ≥55%

储存条件

protect from light

储存温度

−20°C

Amino Acid Sequence

Arg-Lys-Leu-Leu-Trp-NH2

一般描述

组织蛋白酶L抑制剂是一种组蛋白H3加工酶。它在维持表皮稳态、毛囊正常形态发生和周期中起重要作用。组织蛋白酶L参与蛋白降解。它可能会调节免疫系统的正常功能。组织蛋白酶L可调节巨噬细胞死亡、坏死核心形成和动脉粥样硬化斑块不稳定进展。

应用

组织蛋白酶L是一种可代谢胶原蛋白和弹性蛋白的溶酶体半胱氨酸蛋白酶。组织蛋白酶L的作用和活性可借助肽抑制剂如五肽酰胺RKLLW-NH2（Arg-Lys-Leu-Leu-Trp-NH2）而得以研究。

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

法规信息

常规特殊物品

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
E1273
CN0623

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

  1. Which document(s) contains shelf-life or expiration date information for a given product?

    If available for a given product, the recommended re-test date or the expiration date can be found on the Certificate of Analysis.

  2. How do I get lot-specific information or a Certificate of Analysis?

    The lot specific COA document can be found by entering the lot number above under the "Documents" section.

  3. How do I find price and availability?

    There are several ways to find pricing and availability for our products. Once you log onto our website, you will find the price and availability displayed on the product detail page. You can contact any of our Customer Sales and Service offices to receive a quote.  USA customers:  1-800-325-3010 or view local office numbers.

  4. What is the Department of Transportation shipping information for this product?

    Transportation information can be found in Section 14 of the product's (M)SDS.To access the shipping information for this material, use the link on the product detail page for the product. 

  5. Do you have any references for product SCP0110, Cathepsin L Inhibitor?

    Product SCP0110, Cathepsin L inhibitor peptide has the sequence Arg-Lys-Leu-Leu-Trp-NH2, which can be abbreviated RKLLW-NH2.See the following paper for reference: A. Brinker, et al.: Eur. J. Biochem., 267(16), 5085-5092 (2000). Highly potent inhibitors of human cathepsin L identified by screening combinatorial pentapeptide amide collections.

  6. My question is not addressed here, how can I contact Technical Service for assistance?

    Ask a Scientist here.

A Brinker et al.
European journal of biochemistry, 267(16), 5085-5092 (2000-08-10)
By screening a combinatorial pentapeptide amide collection in an inhibition assay, we systematically evaluated the potential of 19 proteinogenic amino acids and seven nonproteinogenic amino acids to serve as building blocks for inhibitors of human cathepsin L. Particularly efficient were
Cathepsin L is significantly associated with apoptosis and plaque destabilization in human atherosclerosis
Li W, et al.
Atherosclerosis, 202(1), 92-102 (2009)
Protease signalling: the cutting edge
Turk B, et al.
The Embo Journal, 31(7), 1630-1643 (2012)
Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells
Liu J, et al.
Atherosclerosis, 184(2), 302-311 (2006)
Brendan Reed et al.
The Journal of experimental medicine, 218(2) (2020-10-24)
The identification of the peptide epitopes presented by major histocompatibility complex class II (MHCII) molecules that drive the CD4 T cell component of autoimmune diseases has presented a formidable challenge over several decades. In type 1 diabetes (T1D), recent insight
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门